Donna Li
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Hepatology top 5%
- Liver physiology and pathology
Papers in
- Oncology 8
- Drug Transport and Resistance Mechanisms 8
-
- Pharmacogenetics and Drug Metabolism 8
- Drug-Induced Hepatotoxicity and Protection 4
- Co-authors
- Erin G. Schuetz (6 shared papers)Philip S. Guzelian (6 shared papers)Barbara A. Elswick (1 shared paper)Curtis J. Omiecinski (1 shared paper)Ursula Müller‐Eberhard (1 shared paper)Philip S. Guzelian (2 shared papers)David T. Molowa (1 shared paper)Robert A. Fisher (1 shared paper)
- Journals
- Archives of Biochemistry and Biophysics (2 papers)Biochemical Pharmacology (2 papers)JNCI Monographs (1 paper)Journal of Cellular Physiology (1 paper)Drug Metabolism Reviews (1 paper)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Donna Li
10 papers receiving 797 citations
Donna Li's Hit Papers
Peers
Comparison fields: 5 of 84
- Pharmacology 422
- Hepatology 196
- Oncology 294
- Biochemistry 59
- Endocrinology, Diabetes and Metabolism 83
Countries citing papers authored by Donna Li
This map shows the geographic impact of Donna Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Li more than expected).
Fields of papers citing papers by Donna Li
This network shows the impact of papers produced by Donna Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Li. The network helps show where Donna Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Donna Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix Hit paper breakdown → | 1988 | 424 |
| 2 | 1993 | 165 | |
| 3 | 1985 | 70 | |
| 4 | 1987 | 48 | |
| 5 | 1991 | 31 | |
| 6 | 1990 | 29 | |
| 7 | 2012 | 28 | |
| 8 | 1993 | 26 | |
| 9 | 1989 | 13 | |
| 10 | 2024 | 7 |
About Donna Li
Donna Li is a scholar working on Oncology, Pharmacology, Molecular Biology, General Health Professions and Economics and Econometrics, having authored 10 papers that have together received 841 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacogenetics and Drug Metabolism (8 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Health Policy Implementation Science (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), Garlic and Onion Studies (1 paper) and Interprofessional Education and Collaboration (1 paper). The work is most often cited by research in Pharmacology (422 citations), Hepatology (196 citations), Oncology (294 citations), Biochemistry (59 citations) and Endocrinology, Diabetes and Metabolism (83 citations). Donna Li has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Erin G. Schuetz, Philip S. Guzelian, Barbara A. Elswick, Curtis J. Omiecinski, Ursula Müller‐Eberhard, Philip S. Guzelian, David T. Molowa, Robert A. Fisher, Stephen C. Strom and Melissa Thompson. Their work appears in journals such as Archives of Biochemistry and Biophysics, Biochemical Pharmacology, JNCI Monographs, Journal of Cellular Physiology and Drug Metabolism Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.